Cytokinetics (CYTK)

0.93 +0.02 +2.20% May 25, 11:00PM Go Pro

Cytokinetics Valuation

No matter how good a company is, if the price that you pay to buy it is too high, you won't make much money. These valuation metrics should give you a sense of reasonable prices, but be careful with them. Always seek to understand why a valuation is changing over time.

Price Multiples

Price Multiples show how much you get for the price you pay. They can fluctuate drastically over time. Looking at price multiples over time and comparing to those of competitors will help to triangulate a reasonable valuation.

Price to Sales Ratio

Tells you how much you are paying for one dollar of sales.

CYTK 14.05

BLRX

ACHN 194.19

VSTM

Price to Earnings Ratio

Tells you how much you are paying for one dollar of earnings.

CYTK 7.442

BLRX

ACHN

VSTM

Price to Book

Tells you how much you are paying for one dollar of net assets (net assets is total assets - total liabilities).

CYTK 1.691

BLRX 1.382

ACHN 8.110

VSTM

Enterprise Valuation

Enterprise Value (EV) multiples tell you what you would get if you were to buy the whole company (including paying off all debt). Similar to price multiples, they can be compared across time and with peers.

EV / EBITDA Pro

Tells you how much you pay for one dollar of earnings before interest, taxes, depreciation and amortization if you were buying the whole company.

CYTK Go Pro

BLRX Go Pro

ACHN Go Pro

VSTM Go Pro

EV / Revenue Pro

Tells you how much you pay for one dollar of sales if you were buying the whole company.

CYTK Go Pro

BLRX Go Pro

ACHN Go Pro

VSTM Go Pro

EV / EBIT Pro

Tells you how much you pay for one dollar of earnings before interest and taxes if you were buying the whole company.

CYTK Go Pro

BLRX Go Pro

ACHN Go Pro

VSTM Go Pro

EV / Free Cash Flow Pro

Tells how much you are paying for one dollar of current free cash flow if you were buying the whole company.

CYTK Go Pro

BLRX Go Pro

ACHN Go Pro

VSTM Go Pro

You may also be interested in these CYTK related companies

Options

CYTK News

Cytokinetics (CYTK) Opens Second Cohort for ATOMIC-AHF Phase IIb
May 24, 8:23AM Street Insider

Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure
May 24, 7:30AM Benzinga

Cytokinetics to Hold Annual Meeting of Stockholders
May 15, 4:00PM Marketwire

$CYTK hod pop
about 19 days ago by tradueruski

$CYTK long and strong
about 19 days ago by tradueruski

Cytokinetics Announces Company Participation and Support of ALS Fundraising Activities in Connection With ALS Awareness Month
May 09, 7:30AM Marketwire

$CYTK filed latest Quarterly Report http://stks.co/3gDG
about 24 days ago by MarketBrief

CYTOKINETICS INC Files SEC form 10-Q, Quarterly Report
May 04, 2:37PM

$CYTK under a buck...
about 24 days ago by swingtrades99

$CYTK forms bearish "Continuation Diamond" chart pattern. http://stks.co/3aqN
about 28 days ago by RecogniaEvents

New Star Analyst Rankings for Cytokinetics, Incorporated
Apr 27, 9:56AM

@ChillzTrading $CYTK total junk
about 32 days ago by lieberlanz

Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c
Apr 26, 5:02PM Street Insider

CYTOKINETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statement
Apr 26, 4:05PM

Cytokinetics, Incorporated Reports First Quarter 2012 Financial Results
Apr 26, 4:00PM Marketwire

Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 at the 2012 Experimental Biology Annual Conference
Apr 26, 7:30AM Marketwire

Q1 2012 Cytokinetics, Inc. Earnings Release - 4:00 pm ET
Apr 26, 7:07AM

@Jamtrades @seekingalpha when they use the term encouiraging it usually means its crap $CYTK
about 33 days ago by lieberlanz

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr 25, 4:37PM

Cytokinetics Announces Encouraging Results From Two Phase II Clinical Trials Evaluating CK-2017357 in Patients With Amyotrophic Lateral Sclerosis
Apr 25, 4:31PM Benzinga

$TRV sold @ 62.60 for 100bux profit. Stepped out of $CYTK @ 1.17 for 100 bux loss. sigh.
about 38 days ago by Rodg3r

$CYTK long some @ 1.22
about 38 days ago by Rodg3r

Cytokinetics to Announce First Quarter Results on April 26, 2012
Apr 19, 4:00PM Marketwire

Cytokinetics ALS drug wins 'fast track' designation
Apr 19, 1:31PM

Cytokinetics (CYTK) Proposed Muscle Troponin Activator Now on FDA's Fast Track
Apr 19, 8:53AM Street Insider

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr 19, 7:36AM

Cytokinetics Announces CK-2017357 Receives Fast Track Designation From the FDA for the Potential Treatment of Amyotrophic Lateral Sclerosis
Apr 19, 7:34AM Benzinga

Cytokinetics' CK-2017357 receives fast track designation from FDA for ALS
Apr 19, 7:32AM

Cytokinetics Announces Clinical Trial Data Relating to CK-2017357 to Be Presented at the 64th Annual Meeting of the American Academy of Neurology
Apr 18, 4:00PM Marketwire

UPDATE: MLV Initiates Cytokinetics with Buy, $4 PT
Apr 12, 12:36PM Benzinga

$CYTK forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/3IOW
about 48 days ago by RecogniaEvents

$CYTK nice
about 49 days ago by tradueruski

$CYTK filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3BjU
about 56 days ago by MarketBrief

@ChillzTrading what is going to happen to $CYTK in april?
about 57 days ago by HuntingtonK

CYTOKINETICS INC Financials
Mar 28, 1:04PM

Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference
Mar 27, 4:13PM Marketwire

@ChiBullsTrader @ChillzTrading Agree! May add position for that event; already have $CYTK for the same conference.
about 68 days ago by Chilltill

@danshep55 Damn, what a great setup was $CYTK but didn't work
about 74 days ago by ivan_bg

$CYTK hod pop
about 75 days ago by tradueruski

$CYTK filed latest Annual Report http://stks.co/2p8G
about 76 days ago by MarketBrief

CYTOKINETICS INC Files SEC form 10-K, Annual Report
Mar 13, 1:55PM

$CYTK forms bullish "Diamond Bottom" chart pattern. http://stks.co/2kad
about 81 days ago by RecogniaEvents

CYTOKINETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Mar 07, 4:08PM

Cytokinetics Announces Changes to Its Board of Directors
Mar 07, 4:00PM Benzinga

$CYTK news huge...BOOOM Taget 2+
about 82 days ago by tradueruski

$ISTA $PPO $ETP $CYTK $MIPS $ACPW $AFFY $CRR $DEXO $MWW all green today, horrible tape
about 83 days ago by HighGrowthFinancial

Cytokinetics ALS drug wins 'orphan' status in Europe
Mar 06, 2:27PM

$CYTK going for hod
about 83 days ago by tradueruski

$CYTK Gappa
about 83 days ago by tradueruski

$CYTK booom on news Target 2
about 83 days ago by tradueruski

$CYTK huge news: http://stks.co/2gj6
about 83 days ago by tradueruski

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar 06, 7:35AM

Cytokinetics (CYTK) Gets EMA Orphan Designation for CK-2017357
Mar 06, 7:33AM Street Insider

Cytokinetics Announces That the European Medicines Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis
Mar 06, 7:32AM Benzinga

InPlay: Cytokinetics announces that the European Medicines Agency has granted CK-2017357 orphan medicinal product designation for the treatment of amyotrophic lateral sclerosis
Mar 06, 7:32AM

CYTOKINETICS INC Files SEC form 8-K, Other Events
Mar 05, 7:34AM

Cytokinetics Announces Fundamental Research in the Field of Fast Skeletal Muscle Activation Published in the Journal Nature Medicine
Mar 05, 7:30AM Marketwire

Cytokinetics to Present at March Healthcare Conferences
Feb 28, 4:00PM Marketwire

Amgen, Cytokinetics start early-stage study of heart drug
Feb 21, 1:52PM

CYTOKINETICS INC Files SEC form 8-K, Other Events
Feb 21, 7:35AM

Cytokinetics Announces Initiation of Phase I Clinical Trial of Oral Formulations of Omecamtiv Mecarbil in Healthy Volunteers
Feb 21, 7:34AM Benzinga

Cytokinetics to Present at BIO CEO and Investor Conference
Feb 06, 4:00PM Marketwire

Cytokinetics, Inc. Earnings Call scheduled for 4:30 pm ET today
Feb 02, 4:30PM

CYTOKINETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Feb 02, 4:24PM

Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Feb 02, 4:13PM Street Insider

Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
Feb 02, 4:00PM Marketwire

Q4 2011 Cytokinetics Inc Earnings Release - 4:00 pm ET
Feb 02, 7:07AM

Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012
Jan 26, 4:00PM Marketwire

Cytokinetics takes a swing at Lou Gehrig's disease
Dec 29, 4:11PM

CYTOKINETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Dec 02, 5:02PM

Cytokinetics announces positive results from CK-2107357 Phase II trial
Nov 30, 7:35AM FlyOnTheWall

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov 30, 7:35AM

Cytokinetics (CYTK) Reports Positive CK-2017357 Phase II, Part A Dat in ALS Patients
Nov 30, 7:32AM Street Insider

Cytokinetics Announces Positive Results From Phase II Clinical
Nov 30, 7:30AM Benzinga

Cytokinetics Announces Positive Results From Phase II Clinical Trial Evaluating CK-2017357 in Patients With Amyotrophic Lateral Sclerosis
Nov 30, 7:30AM Marketwire

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov 29, 7:36AM

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
CYTK	0.93	+0.02	+2.20%	71.03M
CVBK	0.86	-0.08	-8.51%	2.262M
CVA	15.79	-0.03	-0.19%	2.149B
CV	35.13	-0.02	-0.06%	473.55M
CUZ	7.42	+0.09	+1.23%	772.72M
CUTR	6.94	-0.20	-2.80%	96.81M
CUT	16.04	+0.04	+0.24%
CURE	39.59	+0.00	+0.00%
CUR	0.94	-0.01	-1.05%	51.40M
CUK	32.44	+0.02	+0.06%	6.977B

Create Watchlist from Stock Quotes